This message was sent to ##Email##
|
| May 22, 2019 |
| |  | | |
|
|
|
| |
CAP Today
The tight supply of technologists to fill open positions is pushing laboratories to be creative in finding answers. Memorial Sloan Kettering Cancer Center and TriCore Reference Laboratories found their answers by looking not just outward but also — and largely — inward.
READ MORE
| Congratulations to the 2019 Student Presentation Winners!
|
    |
ASCT
ASCT would like to congratulate the winners of this year’s Warren R. Lang award for student interesting case presentations. Each year, ASCT invites currently enrolled cytotechnology students to participate in the ASCT Student Case Presentations program at our annual conference. Up to 10 students are selected to present their case presentation in person. Because we know that not all students can attend the conference, we also invite all students to submit their presentation for a computer loop that is shown during the break time sessions of the conference.
The Warren R. Lang Award was established in 1989 by the ASCT Executive Council in memory of Dr. Warren R. Lang. Dr. Lang was a professor of cytotechnology and medical director of the School of Cytotechnology in the College of Allied Health Sciences of the Thomas Jefferson University in the 1970’s and was later promoted to chair of the department of pathology in 1983. He was a relentless advocate for cytotechnologists, cytology students, and pathology residents and enjoyed teaching immensely.
Currently, students who give case presentations at the Annual Conference are eligible for this award. The first-place winner receives $150 and a one-year membership to the ASCT. The second and third-place winners receive $100 and $50, respectively. The computer presentation winner receives $50 in ASCT Bucks.
This year’s winners:
1st place: Morgan Carey, Indiana University School of Medicine
2nd place (tie): Angelica Carter, Indiana University School of Medicine and Chelsea Grasser, University of Arkansas for Medical Sciences
3rd place: Taylor Jackson, University of Arkansas for Medical Sciences
Computer Presentation Winner: Kevin Tran, UCLA School of Cytotechnology
 |
|
EcoVue® was designed with patient safety in mind, our non-refillable and single use products will forever CHANGE YOUR VUE of ultrasound gel.
www.EcoVue.com
|
|
| Date |
Event |
Location |
More information |
June 2019 |
The Engagement of Cytotechnologists in Genomic Selections Leads to
Improved Outcomes
|
your PC |
Melissa Randolph, BS, SCT(ASCP)
Details
|
July, 17 2019 |
TBA
|
your PC |
Eva Wojcik, MD
Department of Pathology
Loyola University Medical Center - Chicago
Details
|
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
May 3 - 5, 2019 |
2019 ASCT Annual Conference
|
San Juan, Puerto Rico |
Details |
Medscape (free login required)
"The exponential increase in oropharynx cancer incidence in young white US men has ebbed," say the authors of a new study, who also report that "modest increases are occurring/anticipated in cohorts born after 1955." The new data come from a study published online in the Journal of Clinical Oncology. The last two decades have seen an "epidemic" increase in the incidence of oropharynx cancers in young white men related to infection with the human papillomavirus, as previously reported by Medscape Medical News. The study suggests that age demographics are shifting.
READ MORE
WJBK-TV
When it comes to screening for one of the most preventable cancers in young women, doctors say women aren't getting the tests they need. It's being called a disturbing trend when it comes to a cancer screening and young women: doctors are noticing women in their 20s seem to be avoiding a test that will detect cervical cancer early. "What they found was if you asked the question, 'How many women that are between 21 and 29 have gotten pap smear screening according to the new guidelines?' and the answer is — roughly half," says Cleveland Clinic Dr. Robert Debernardo.
READ MORE
CAP Today
Colorectal cancer is the third most diagnosed cancer and the second highest cause of cancer mortality in men and women, and in 2016 it accounted for about nine percent of all diagnosed cancers in the U.S.
READ MORE
The Medical News
A new genomics study has found that men are three times more likely to die from prostate cancer if they possess mutations the retinoblastoma 1 gene. The researchers also found that men with the mutation were seven times more likely to relapse than men without the mutation.
READ MORE
Healio
Detection of persistent HPV DNA in oral rinses appeared associated with greater risk for disease recurrence and death among patients with HPV-positive oral and oropharyngeal squamous cell carcinoma, according to study results published in JAMA Oncology. The results suggest HPV DNA has potential as a biomarker for progression risk and treatment response among this patient population.
READ MORE
The Philadelphia Inquirer via Chicago Tribune
While cancer of the anus the short canal at the end of the rectum through which solid waste leaves the body remains fairly rare, it has been steadily increasing for several decades, and far more women than men develop it. The American Cancer Society estimates that about 5,530 women and 2,770 men will be diagnosed this year; about 760 women and 520 men will die. In response to this alarming trend, leading experts specialists in oncology, pathology, gynecology, infectious diseases, and more believe it's time to start screening some women for anal cancer.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
